GCP roles of sponsors and monitors MCQs With Answer — This concise introduction explains the essential Good Clinical Practice (GCP) responsibilities of clinical trial sponsors and monitors for B.Pharm students. Understand sponsor duties such as trial design, regulatory submissions, safety reporting, trial master file maintenance, and oversight of investigational product management. Learn monitor responsibilities including site initiation, source data verification, on-site and remote monitoring, corrective actions, and ensuring protocol compliance and data integrity. These topics connect directly to regulatory compliance, pharmacovigilance, risk-based monitoring, audits, and inspections—key areas for pharmacy graduates entering clinical research. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. What is the primary regulatory responsibility of a trial sponsor under GCP?
- Conducting all site monitoring visits personally
- Ensuring trial quality, participant safety, and regulatory compliance
- Manufacturing the investigational product
- Providing patient care during the trial
Correct Answer: Ensuring trial quality, participant safety, and regulatory compliance
Q2. Which document is the sponsor primarily responsible for maintaining throughout the trial?
- Patient medical records at the site
- Trial Master File (TMF)
- Hospital inventory log
- Ethics committee minutes only
Correct Answer: Trial Master File (TMF)
Q3. What is a monitor’s main objective during on-site visits?
- To write the trial protocol
- To verify source data and ensure protocol compliance
- To recruit participants for other trials
- To manage the sponsor’s finances
Correct Answer: To verify source data and ensure protocol compliance
Q4. Which task is typically performed by a sponsor rather than a monitor?
- Source data verification
- Preparing regulatory submissions (e.g., IND/CTA)
- Site initiation training
- Documenting monitoring visit reports
Correct Answer: Preparing regulatory submissions (e.g., IND/CTA)
Q5. What does risk-based monitoring prioritize?
- Equal frequency of visits to all sites
- Focusing resources on critical data and high-risk sites
- Only remote monitoring
- Eliminating source data verification
Correct Answer: Focusing resources on critical data and high-risk sites
Q6. Which of the following is a sponsor responsibility for investigational product management?
- Writing informed consent forms at each site
- Ensuring proper labeling, storage, and supply chain control
- Performing on-site IP dispensing
- Recruiting site pharmacists
Correct Answer: Ensuring proper labeling, storage, and supply chain control
Q7. Which action is part of a monitor’s corrective and preventive action (CAPA) role?
- Authorizing the trial protocol
- Identifying deviations and guiding site remediation
- Submitting marketing applications
- Designing the investigational product
Correct Answer: Identifying deviations and guiding site remediation
Q8. Who is responsible for timely reporting of serious adverse events (SAEs) to regulators?
- The site laboratory only
- The study sponsor, in collaboration with the investigator
- Local hospital administration
- The patient’s family
Correct Answer: The study sponsor, in collaboration with the investigator
Q9. What is the purpose of a monitoring plan?
- To train participants in lab procedures
- To define monitoring strategies, frequency, and scope
- To replace the protocol
- To manage sponsor payroll
Correct Answer: To define monitoring strategies, frequency, and scope
Q10. Which document details delegated responsibilities at a trial site?
- Investigator brochure
- Delegation log (or site staff delegation of duties)
- Case report form only
- Shipping manifest
Correct Answer: Delegation log (or site staff delegation of duties)
Q11. What is source data verification (SDV)?
- Checking lab reagent quality
- Comparing entered CRF data with original source documents
- Verifying sponsor invoices
- Monitoring the freezer temperature only
Correct Answer: Comparing entered CRF data with original source documents
Q12. Which activity is part of sponsor oversight of subcontractors?
- Allowing subcontractors to work unsupervised
- Qualifying, auditing, and managing vendor performance
- Delegating ethics approval to vendors
- Transferring regulatory responsibility to vendors
Correct Answer: Qualifying, auditing, and managing vendor performance
Q13. What qualifies a person to act as a monitor under GCP?
- No experience required
- Appropriate education, training, and monitoring experience
- Only a medical degree
- Only administrative staff
Correct Answer: Appropriate education, training, and monitoring experience
Q14. Who ensures informed consent is properly obtained and documented?
- The sponsor exclusively
- The investigator at the site, overseen by the sponsor
- The monitor during every visit
- Regulatory authority
Correct Answer: The investigator at the site, overseen by the sponsor
Q15. Which is an essential element of the Trial Master File?
- Patient financial records
- Essential documents showing trial conduct and compliance
- Every investigator’s personal notes
- Only regulatory correspondence
Correct Answer: Essential documents showing trial conduct and compliance
Q16. What is the monitor’s role during a site initiation visit?
- To sign ethics approvals
- To train site staff on protocol, GCP, and study procedures
- To manufacture the investigational product
- To recruit the ethics committee
Correct Answer: To train site staff on protocol, GCP, and study procedures
Q17. Which of the following best describes central monitoring?
- Monitoring that only happens during on-site visits
- Remote review of aggregated data to detect trends and issues
- Only monitoring of investigational product
- Monitoring performed by the ethics committee
Correct Answer: Remote review of aggregated data to detect trends and issues
Q18. How soon must an unexpected serious adverse reaction be reported to authorities, generally?
- Within 24 hours for all events
- As specified by local regulations; often within 7–15 days
- After trial completion only
- Only when requested by the site
Correct Answer: As specified by local regulations; often within 7–15 days
Q19. Which GCP requirement applies to the qualifications of investigators?
- They must be qualified by education, training, and experience
- They need only a university degree in any field
- No documentation of qualifications is needed
- Only a local license is sufficient without training
Correct Answer: They must be qualified by education, training, and experience
Q20. Which record helps track investigational product accountability at sites?
- Case Report Form (CRF)
- Drug accountability log
- Ethics approval letter
- Patient consent form alone
Correct Answer: Drug accountability log
Q21. What is a primary difference between an auditor and a monitor?
- Monitors inspect finances; auditors ensure protocol compliance
- Auditors assess compliance independently; monitors provide ongoing oversight and support
- They are the same role
- Monitors work for regulators only
Correct Answer: Auditors assess compliance independently; monitors provide ongoing oversight and support
Q22. Who must ensure that study staff receive GCP training?
- The site’s hospital administration only
- The sponsor, in collaboration with the investigator
- Only the ethics committee
- Participants themselves
Correct Answer: The sponsor, in collaboration with the investigator
Q23. Which activity is included in monitoring reports?
- Site recruitment targets for unrelated trials
- Findings, action items, and follow-up recommendations
- Financial audits of the investigator’s private accounts
- Patient billing information
Correct Answer: Findings, action items, and follow-up recommendations
Q24. When a monitor detects noncompliance, what is the expected sponsor action?
- Ignore the issue if recruitment is good
- Initiate CAPA and ensure corrective measures are implemented
- Terminate the site immediately without investigation
- Transfer responsibility to the participant
Correct Answer: Initiate CAPA and ensure corrective measures are implemented
Q25. Which document provides investigators with clinical and safety information about the investigational product?
- Investigator’s brochure (IB)
- Trial master file index
- Drug accountability log
- Monitoring visit log
Correct Answer: Investigator’s brochure (IB)
Q26. What is the sponsor’s responsibility regarding insurance or indemnity for trial participants?
- No responsibility at all
- To ensure appropriate insurance or indemnity provisions are in place
- Only the site handles all insurance matters
- To provide personal legal advice to participants
Correct Answer: To ensure appropriate insurance or indemnity provisions are in place
Q27. Which is an essential monitor qualification related to communication?
- Ability to perform complex lab tests
- Effective communication skills for liaising with site staff and sponsor
- Authoring regulatory legislation
- Only advanced statistical training
Correct Answer: Effective communication skills for liaising with site staff and sponsor
Q28. What should a sponsor do before delegating trial tasks to a contract research organization (CRO)?
- Sign people up without oversight
- Assess and document the CRO’s qualifications and responsibilities
- Allow the CRO to operate without contractual terms
- Transfer all regulatory liability completely
Correct Answer: Assess and document the CRO’s qualifications and responsibilities
Q29. Which activity helps ensure data integrity during monitoring?
- Ignoring query resolution
- Timely query management and source data checks
- Altering source documents to match CRFs
- Delaying data entry indefinitely
Correct Answer: Timely query management and source data checks
Q30. What role does the sponsor play in preparing for regulatory inspections?
- No preparation is needed
- Ensuring complete documentation, readiness of TMF, and coordination with sites
- Allowing sites to handle inspections without support
- Removing all trial documents before inspection
Correct Answer: Ensuring complete documentation, readiness of TMF, and coordination with sites
